Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06605625
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-18
Brief Title:
Vaccine Responses in Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Vaccine Responses in Cancer
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VRiC
Brief Summary:
The investigators are conducting a prospective unblinded study of individuals diagnosed with cancer who will receive one or more of the following influenza SARS-CoV2 and shingles
Detailed Description:
Vaccinations are indicated for all adults but the immunogenicity of vaccination has not been assessed in all situations In particular immune responses following vaccination have not been studied in the setting of cancer and in the context of various anti-tumor treatments In this study the investigators will look at the immune response of subjects receiving vaccination
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None